COMPANY PROFILE // THE 014 REPORT
Hemab Therapeutics Holdings, Inc.
COAG (Nasdaq)
Assembled from 2 government sources in 0.1 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
No flag from the records checked. 26 of 26 lists and sources checked came back clear (panel below).
✓ SEC filings✓ State registrationpossible match✗ LEI✗ SAM registration✗ IRS return✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no website, no lobbying registration on record.
Hemab Therapeutics Holdings, Inc. is an SEC-registered operating company in biological products, (no diagnostic substances), incorporated in DE, based in Cambridge, MA; listed as COAG (Nasdaq).[source] It has filed 53 documents with the SEC in the last 12 months; the latest is Form 10-Q, filed 2026-11-10.[source] Its largest institutional holders on 13F filings are RA CAPITAL MANAGEMENT, L.P., NOVO HOLDINGS A/S, FMR LLC (as of 2026-06-30).[source] Every list and source checked for this page came back clear (26 of 26), dated in the checks panel.[source]
- red0
- amber0
- info0
- RA CAPITAL MANAGEMENT, L.P.$286.8M
- NOVO HOLDINGS A/S$153.6M
- FMR LLC$135.8M
- Capital International Investors$132.4M
- Deep Track Capital, LP$132.3M
- Siren, L.L.C.$76.6M
- Avoro Capital Advisors LLC$70.7M
- Bain Capital Life Sciences Investors, LLC$60.6M
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Legal counsel, as publicly named
- Wilmer Cutler Pickering Hale and Dorr LLP · Exhibit 5.1 legal opinion, S-8 filed 2026-05-04
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0002114044 | source |
| EIN | 41-4241952 | source |
| Business address (SEC) | 101 MAIN STREET, CAMBRIDGE, MA, 02142 | source |
Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-03-31 · in 131 days · Next 10-K due (period ended 2026-12-31; Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company) (computed from the fiscal year end and filer status)
- 2027-05-15 · in 176 days · Next 10-Q due (period ended 2027-03-31; Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 2836 (biological products, (no diagnostic substances)): 183 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- AMGEN INC · 123 SEC filings in 12 months · 1 flag · $507.4M federal (possible match)
- Vir Biotechnology, Inc. · 117 SEC filings in 12 months · 1 flag · $65.9M federal (possible match)
- Vericel Corp · 109 SEC filings in 12 months · 1 flag · $37.3M federal (possible match)
- Coherus Oncology, Inc. · 53 SEC filings in 12 months · 3 flags · $11.8M federal (possible match)
- BIO-TECHNE Corp · 77 SEC filings in 12 months · 1 flag · $6.6M federal (possible match)
- Twist Bioscience Corp · 337 SEC filings in 12 months · 2 flags · $5.9M federal (possible match)
- Adaptive Biotechnologies Corp · 185 SEC filings in 12 months · 1 flag · $1.9M federal (possible match)
- AGENUS INC · 82 SEC filings in 12 months · 3 flags · $613K federal (possible match)
- REPLIGEN CORP · 89 SEC filings in 12 months · 1 flag · $457K federal (possible match)
- Revolution Medicines, Inc. · 171 SEC filings in 12 months · 2 flags · $15K federal (possible match)
- RECURSION PHARMACEUTICALS, INC. · 174 SEC filings in 12 months · 1 flag
- GILEAD SCIENCES, INC. · 173 SEC filings in 12 months
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-11-10 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-11-10 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-09-24 officer change 8-K items 5.02 · SEC EDGAR
- 2026-08-11 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-08-11 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-05-21 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-05-21 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-05-11 filing SCHEDULE 13D · SEC EDGAR
- 2026-05-11 officer change 8-K items 5.02 · SEC EDGAR
- 2026-05-04 filing 8-K items 5.03,8.01,9.01 · SEC EDGAR
- 2026-05-04 filing S-8 · SEC EDGAR
- 2026-05-01 filing 424B4 · SEC EDGAR
- 2026-04-30 filing EFFECT · SEC EDGAR
- 2026-04-30 filing S-1MEF · SEC EDGAR
- 2026-04-30 filing CERT · SEC EDGAR
- 2026-04-30 filing S-1/A · SEC EDGAR
- 2026-04-28 filing S-1/A · SEC EDGAR
- 2026-04-27 filing 8-A12B · SEC EDGAR
- 2026-04-27 filing S-1/A · SEC EDGAR
- 2026-04-10 filing Registration (S-1) · SEC EDGAR
- 2026-04-02 filing DRS/A · SEC EDGAR
- 2026-02-27 filing DRS · SEC EDGAR
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-10 (within 30 days) 10-Q filed
- 2026-11-10 (within 30 days) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-09-24 (older) 8-K filed: Item 5.02 officer or director change
- 2026-08-11 (older) 10-Q filed
- 2026-08-11 (older) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-05-21 (older) 10-Q filed
- 2026-05-21 (older) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-05-11 (older) 8-K filed: Item 5.02 officer or director change
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-20; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:COAG The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
1 possible match held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 2114044 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | COAG / Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| EIN | 414241952 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0002114044 | SEC EDGAR / IRS |
| CUSIP | 423494103 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0002114044 | SEC EDGAR |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-10 | SEC EDGAR company profile | as filed | 2026-11-20 04:35 UTC | Report an error |
| SIC industry | 2836 Biological Products, (No Diagnostic Substances) | 2026-11-10 | SEC EDGAR company profile | as filed | 2026-11-20 04:35 UTC | Report an error |
| State of incorporation | DE | 2026-11-10 | SEC EDGAR company profile | as filed | 2026-11-20 04:35 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-10 | SEC EDGAR company profile | as filed | 2026-11-20 04:35 UTC | Report an error |
| Business address | 101 MAIN STREET, SUITE 1220, CAMBRIDGE, MA, 02142 | 2026-11-10 | SEC EDGAR company profile | as filed | 2026-11-20 04:35 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-10 | SEC EDGAR company profile | as filed | 2026-11-20 04:35 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-10 · accession 0001193125-26-455376
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Net income (loss) | -$27,304,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-10 | 0001193125-26-455376 | 2026-11-20 04:35 UTC | Report an error |
| Cash and cash equivalents | $239,149,000 | at 2026-09-30 | 10-Q | 2026-11-10 | 0001193125-26-455376 | 2026-11-20 04:35 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-10 Filing 10-Q filed
- 2026-11-10 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-09-24 Filing 8-K filed: Item 5.02 officer or director change
- 2026-08-11 Filing 10-Q filed
- 2026-08-11 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-05-21 Filing 10-Q filed
- 2026-05-21 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-05-11 Filing 8-K filed: Item 5.02 officer or director change
- 2026-05-04 Filing 8-K filed: Item 5.03 charter or bylaw amendment; Item 8.01 other event; Item 9.01 exhibits
- 2026-05-04 Filing S-8 filed
- 2026-05-01 Filing 424B4 filed
- 2026-04-30 Filing EFFECT filed
- 2026-04-30 Filing S-1MEF filed
- 2026-04-30 Filing CERT filed
- 2026-04-30 Filing S-1/A filed
- 2026-04-28 Filing S-1/A filed
- 2026-04-27 Filing 8-A12B filed
- 2026-04-27 Filing S-1/A filed
- 2026-04-10 Filing S-1 filed
- 2026-04-02 Filing DRS/A filed
- 2026-02-27 Filing DRS filed
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | $286,810,870 | 2026-06-30 | SEC 13F filing | 2026-11-20 04:35 UTC | Report an error |
| 2 | NOVO HOLDINGS A/S | $153,551,602 | 2026-06-30 | SEC 13F filing | 2026-11-20 04:35 UTC | Report an error |
| 3 | FMR LLC | $135,821,553 | 2026-06-30 | SEC 13F filing | 2026-11-20 04:35 UTC | Report an error |
| 4 | Capital International Investors | $132,370,365 | 2026-06-30 | SEC 13F filing | 2026-11-20 04:35 UTC | Report an error |
| 5 | Deep Track Capital, LP | $132,304,876 | 2026-06-30 | SEC 13F filing | 2026-11-20 04:35 UTC | Report an error |
| 6 | Siren, L.L.C. | $76,649,413 | 2026-06-30 | SEC 13F filing | 2026-11-20 04:35 UTC | Report an error |
| 7 | Avoro Capital Advisors LLC | $70,710,760 | 2026-06-30 | SEC 13F filing | 2026-11-20 04:35 UTC | Report an error |
| 8 | Bain Capital Life Sciences Investors, LLC | $60,604,500 | 2026-06-30 | SEC 13F filing | 2026-11-20 04:35 UTC | Report an error |
| 9 | JPMORGAN CHASE & CO | $42,328,387 | 2026-06-30 | SEC 13F filing | 2026-11-20 04:35 UTC | Report an error |
| 10 | VANGUARD CAPITAL MANAGEMENT LLC | $28,677,241 | 2026-06-30 | SEC 13F filing | 2026-11-20 04:35 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS13. Permits and local records
1 state and city record carry this company's exact name, from 1 source. Possible matches only.
State licences (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchHEMAB THERAPEUTICS HOLDINGS, INC · exact legal name · sx:elic:ctcred:2910690 Compare
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/2114044.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0002114044. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.